Physician profile
Catherine A Schaefer
NPI 1457303992
$1,374.79
in general payments reported to CMS, 2019-2025
17 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.00 · 2021: $182 · 2022: $251 · 2023: $110 · 2024: $387 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $219.52 | 2021-2025 | Ozempic, Rybelsus |
| Horizon Therapeutics Plc | $192.98 | 2020-2023 | Krystexxa |
| Phathom Pharmaceuticals, INC. | $172.01 | 2024 | Voquezna |
| Stryker Corporation | $148.92 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Glaxosmithkline, LLC. | $124.43 | 2020-2025 | Arexvy |
| Amgen INC. | $76.85 | 2024 | Krystexxa |
| Novartis Pharmaceuticals Corporation | $68.58 | 2022-2025 | |
| Abbvie INC. | $61.40 | 2025 | |
| Currax Pharmaceuticals LLC | $52.99 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.32 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $45.92 | 2024 | Rexulti |
| Pfizer INC. | $39.73 | 2022-2024 | |
| Boston Scientific Corporation | $34.67 | 2022 | |
| Insulet Corporation | $31.07 | 2024 | Omnipod |
| Lilly USA, LLC | $27.77 | 2021-2024 | Mounjaro |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.43 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $14.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.